ArticleDiabetology & metabolic syndrome2025

Efficacy and safety of metformin versus empagliflozin on chronic kidney disease progression (MET-EMPA-CKD): a randomized controlled trial.

Bassant M Mahboub et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.